Pharma News
-
{
- All
- News
- Videos
-
Novo Nordisk Partners With OpenAI To Accelerate Drug Discovery
The company said Artificial Intelligence will be used to analyse complex datasets, identify potential drug candidates and reduce the time taken to move from research to clinical application.
-
Novo Nordisk Partners With OpenAI To Accelerate Drug Discovery
The company said Artificial Intelligence will be used to analyse complex datasets, identify potential drug candidates and reduce the time taken to move from research to clinical application.
-
Cabinet Approves Sale Of Surplus Land Of 4 Pharma PSUs
Government approved sale of surplus land of four pharmaceutical public sector undertakings to meet their outstanding liabilities, after which steps to close two units will be taken up.
-
Sun Pharma Launches Cancer Drug In Europe, Shares Gain
Drug major Sun Pharmaceutical Industries Ltd on Monday announced the launch of ready-to-administer cancer drug Gemcitabine InfuSMART in Europe.
-
Aurobindo Pharma To Buy Portugal's Generis For Around Rs 969 Crore
The company has inked a binding agreement through its wholly-owned subsidiary Agile Pharma BV Netherlands to acquire Generis Farmaceutica for a total consideration of 135 million euros, Aurobindo Pharma said in a statement.
-
Aurobindo Pharma To Buy Portugal's Generis For Around Rs 969 Crore
The company has inked a binding agreement through its wholly-owned subsidiary Agile Pharma BV Netherlands to acquire Generis Farmaceutica for a total consideration of 135 million euros, Aurobindo Pharma said in a statement.
-
Cabinet Approves Sale Of Surplus Land Of 4 Pharma PSUs
Government approved sale of surplus land of four pharmaceutical public sector undertakings to meet their outstanding liabilities, after which steps to close two units will be taken up.
-
Sun Pharma Completes Divestment Of 7 Brands To RPG Life
Sun Pharmaceutical Industries completed the divestment of its seven prescription brands in India to RPG Life Sciences.
-
Geistlich Pharma Enters Indian Market
Geistlich Pharma AG announced the commencement of Indian operations with establishment of its 10th global affiliate, Geistlich Pharma India, a wholly-owned subsidiary.
-
S&P Assigns 'BB-' Rating To Jubilant Pharma
Global rating agency S&P has assigned preliminary speculative grade 'BB-' corporate long-term credit rating to Jubilant Pharma (JPL) with a stable outlook.
-
Sun Pharma Inks Distribution Alliance With Mitsubishi Tanabe
Drug major Sun Pharma has announced initiation of a phased transfer of manufacturing and marketing rights of 14 brands, it acquired from Swiss drug firm Novartis in Japan, earlier this year for $293 million.
-
FDA Warns Former Sun Pharma US Drug Factory Over Quality Concerns
The US Food and Drug Administration has pulled up a former Sun Pharmaceutical drug factory for "knowingly" releasing 27 lots of the hypertension drug clonidine last year, despite proof that the raw materials used may have been contaminated.
-
US Rules In Mylan's Favour, Invalidates Teva Patents: Natco
Drug firm Natco Pharma said the US Patent and Trademark Office has ruled in favour of its marketing partner Mylan by invalidating two of Israel-based Teva Pharmaceuticals' patents related to multiple sclerosis drug Copaxone 40 mg/mL.
-
Sun Pharma Promoter Firm pledges 1 Crore Shares To SBI
Sun Pharmaceutical Industries said Virtuous Finance, part of the promoter group has pledged one crore shares of the company amounting to 0.42 per cent stake to State Bank of India.
-
Sun Pharma Gets USFDA Nod For Cholesterol Drug
Drug major Sun Pharma has received final approval from the US health regulator USFDA for rosuvastatin calcium tablets, used in lowering cholesterol.
-
Novo Nordisk Partners With OpenAI To Accelerate Drug Discovery
The company said Artificial Intelligence will be used to analyse complex datasets, identify potential drug candidates and reduce the time taken to move from research to clinical application.
-
Novo Nordisk Partners With OpenAI To Accelerate Drug Discovery
The company said Artificial Intelligence will be used to analyse complex datasets, identify potential drug candidates and reduce the time taken to move from research to clinical application.
-
Cabinet Approves Sale Of Surplus Land Of 4 Pharma PSUs
Government approved sale of surplus land of four pharmaceutical public sector undertakings to meet their outstanding liabilities, after which steps to close two units will be taken up.
-
Sun Pharma Launches Cancer Drug In Europe, Shares Gain
Drug major Sun Pharmaceutical Industries Ltd on Monday announced the launch of ready-to-administer cancer drug Gemcitabine InfuSMART in Europe.
-
Aurobindo Pharma To Buy Portugal's Generis For Around Rs 969 Crore
The company has inked a binding agreement through its wholly-owned subsidiary Agile Pharma BV Netherlands to acquire Generis Farmaceutica for a total consideration of 135 million euros, Aurobindo Pharma said in a statement.
-
Aurobindo Pharma To Buy Portugal's Generis For Around Rs 969 Crore
The company has inked a binding agreement through its wholly-owned subsidiary Agile Pharma BV Netherlands to acquire Generis Farmaceutica for a total consideration of 135 million euros, Aurobindo Pharma said in a statement.
-
Cabinet Approves Sale Of Surplus Land Of 4 Pharma PSUs
Government approved sale of surplus land of four pharmaceutical public sector undertakings to meet their outstanding liabilities, after which steps to close two units will be taken up.
-
Sun Pharma Completes Divestment Of 7 Brands To RPG Life
Sun Pharmaceutical Industries completed the divestment of its seven prescription brands in India to RPG Life Sciences.
-
Geistlich Pharma Enters Indian Market
Geistlich Pharma AG announced the commencement of Indian operations with establishment of its 10th global affiliate, Geistlich Pharma India, a wholly-owned subsidiary.
-
S&P Assigns 'BB-' Rating To Jubilant Pharma
Global rating agency S&P has assigned preliminary speculative grade 'BB-' corporate long-term credit rating to Jubilant Pharma (JPL) with a stable outlook.
-
Sun Pharma Inks Distribution Alliance With Mitsubishi Tanabe
Drug major Sun Pharma has announced initiation of a phased transfer of manufacturing and marketing rights of 14 brands, it acquired from Swiss drug firm Novartis in Japan, earlier this year for $293 million.
-
FDA Warns Former Sun Pharma US Drug Factory Over Quality Concerns
The US Food and Drug Administration has pulled up a former Sun Pharmaceutical drug factory for "knowingly" releasing 27 lots of the hypertension drug clonidine last year, despite proof that the raw materials used may have been contaminated.
-
US Rules In Mylan's Favour, Invalidates Teva Patents: Natco
Drug firm Natco Pharma said the US Patent and Trademark Office has ruled in favour of its marketing partner Mylan by invalidating two of Israel-based Teva Pharmaceuticals' patents related to multiple sclerosis drug Copaxone 40 mg/mL.
-
Sun Pharma Promoter Firm pledges 1 Crore Shares To SBI
Sun Pharmaceutical Industries said Virtuous Finance, part of the promoter group has pledged one crore shares of the company amounting to 0.42 per cent stake to State Bank of India.
-
Sun Pharma Gets USFDA Nod For Cholesterol Drug
Drug major Sun Pharma has received final approval from the US health regulator USFDA for rosuvastatin calcium tablets, used in lowering cholesterol.
